Multiple mutations in IDH isoenzymes IDH1 and IDH2, which normally catalyze oxidative decarboxylation of isocitrate to α-KG, have been shown to occur frequently in gliomas and acute myeloid leukemia [174,175,176]. Here, IDH2 is linked to glioma.